Axon Enterprise, Inc. Total Cost of Revenue decreased by 1.6% to $330.06M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.7%, from $237.89M to $330.06M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 36.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $80.87M | $87.42M | $79.96M | $100.69M | $111.65M | $118.50M | $130.20M | $139.88M | $142.36M | $156.62M | $166.38M | $201.24M | $197.08M | $213.53M | $229.30M | $237.89M | $264.80M | $283.29M | $335.43M | $330.06M |
| QoQ Change | — | +8.1% | -8.5% | +25.9% | +10.9% | +6.1% | +9.9% | +7.4% | +1.8% | +10.0% | +6.2% | +21.0% | -2.1% | +8.3% | +7.4% | +3.7% | +11.3% | +7.0% | +18.4% | -1.6% |
| YoY Change | — | — | — | — | +38.1% | +35.5% | +62.8% | +38.9% | +27.5% | +32.2% | +27.8% | +43.9% | +38.4% | +36.3% | +37.8% | +18.2% | +34.4% | +32.7% | +46.3% | +38.7% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Connected Devices | — | — | — | -$170.18M | $193.51M | $203.17M | $242.44M | -$232.16M |
| Software and Services | $54.45M | $57.36M | $62.11M | -$67.71M | — | — | — | — |
| TASER | $84.66M | $84.66M | $84.66M | — | — | — | — | — |
| Total | $197.08M | $213.53M | $229.30M | $237.89M | $264.80M | $283.29M | $335.43M | $330.06M |
TASER was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q1 '22 | Q2 '22 | Q3 '22 | Q2 '24 | Q3 '24 | Q1 '25 |
|---|---|---|---|---|---|---|
| Softwareand Sensors | $60.06M | $63.19M | $65.08M | $54.45M | $57.36M | -$67.71M |
| Total | $100.69M | $111.65M | $118.50M | $197.08M | $213.53M | $237.89M |
Softwareand Sensors was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.